Dai ichi Life Insurance Company Ltd grew its stake in shares of Coca-Cola Europacific Partners PLC (NASDAQ:CCEP – Free Report) by 30.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 18,878 shares of the company’s stock after buying an additional 4,400 shares during the quarter. Dai ichi Life Insurance Company Ltd’s holdings in Coca-Cola Europacific Partners were worth $1,487,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of the stock. Lombard Odier Asset Management Europe Ltd grew its position in Coca-Cola Europacific Partners by 103.4% during the 2nd quarter. Lombard Odier Asset Management Europe Ltd now owns 92,770 shares of the company’s stock worth $6,760,000 after acquiring an additional 47,165 shares during the last quarter. Cetera Advisors LLC boosted its stake in shares of Coca-Cola Europacific Partners by 234.1% during the first quarter. Cetera Advisors LLC now owns 10,325 shares of the company’s stock valued at $722,000 after purchasing an additional 7,235 shares in the last quarter. Diversified Trust Co bought a new stake in shares of Coca-Cola Europacific Partners during the third quarter worth about $2,513,000. Manning & Napier Advisors LLC acquired a new position in shares of Coca-Cola Europacific Partners in the second quarter valued at approximately $3,068,000. Finally, Marshall Wace LLP bought a new position in Coca-Cola Europacific Partners in the 2nd quarter valued at approximately $1,846,000. 31.35% of the stock is currently owned by institutional investors and hedge funds.
Coca-Cola Europacific Partners Price Performance
Shares of CCEP opened at $77.63 on Thursday. Coca-Cola Europacific Partners PLC has a 52-week low of $59.31 and a 52-week high of $82.32. The business’s 50 day moving average price is $77.67 and its two-hundred day moving average price is $76.17. The company has a debt-to-equity ratio of 1.12, a current ratio of 0.85 and a quick ratio of 0.63.
Coca-Cola Europacific Partners Increases Dividend
Analyst Ratings Changes
CCEP has been the topic of a number of research reports. BNP Paribas lowered shares of Coca-Cola Europacific Partners from an “outperform” rating to a “neutral” rating and set a $81.00 target price on the stock. in a report on Tuesday, September 10th. Deutsche Bank Aktiengesellschaft increased their price objective on Coca-Cola Europacific Partners from $78.00 to $90.00 and gave the company a “buy” rating in a report on Monday, September 9th. Barclays lifted their target price on Coca-Cola Europacific Partners from $84.00 to $86.00 and gave the stock an “overweight” rating in a report on Thursday, November 7th. Evercore ISI increased their price target on Coca-Cola Europacific Partners from $78.00 to $82.00 and gave the company an “outperform” rating in a research note on Wednesday, November 6th. Finally, JPMorgan Chase & Co. lowered Coca-Cola Europacific Partners from an “overweight” rating to a “neutral” rating and cut their price objective for the stock from $85.00 to $82.00 in a research note on Wednesday. Three research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $81.78.
Check Out Our Latest Stock Report on Coca-Cola Europacific Partners
About Coca-Cola Europacific Partners
Coca-Cola Europacific Partners PLC, together with its subsidiaries, produces, distributes, and sells a range of non-alcoholic ready to drink beverages. It offers flavours, mixers, and energy drinks; soft drinks, waters, enhanced water, and isotonic drinks; and ready-to-drink tea and coffee, juices, and other drinks.
Further Reading
- Five stocks we like better than Coca-Cola Europacific Partners
- What is an Earnings Surprise?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Effectively Use the MarketBeat Ratings Screener
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Invest in Small Cap StocksĀ
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding CCEP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Coca-Cola Europacific Partners PLC (NASDAQ:CCEP – Free Report).
Receive News & Ratings for Coca-Cola Europacific Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coca-Cola Europacific Partners and related companies with MarketBeat.com's FREE daily email newsletter.